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Background: Feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) are reported to have similar risk
factors and similar recommendations apply to manage infected cats. However, some contrasting evidence exists in
the literature with regard to commonly reported risk factors. In this study, we investigated whether the known risk
factors for FIV and FeLV infections have a stronger effect for either infection. This retrospective study included
samples from 696 cats seropositive for FIV and 593 cats seropositive for FeLV from the United States and Canada.
Data were collected during two cross sectional studies, where cats were tested using IDEXX FIV/FeLV ELISA kits. To
compare the effect of known risk factors for FIV infection compared to FeLV, using a case-case study design, ran-
dom intercept logistic regression models were fit including cats’ age, sex, neuter status, outdoor exposure, health
status and type of testing facility as independent variables. A random intercept for testing facility was included to
account for clustering expected in testing practices at the individual clinics and shelters.
Results: In the multivariable random intercept model, the odds of FIV compared to FeLV positive ELISA
results were greater for adults (OR = 2.09, CI: 1.50-2.92), intact males (OR = 3.14, CI: 1.85-3.76), neutered
males (OR = 2.68, CI: 1.44- 3.14), cats with outdoor access (OR = 2.58, CI: 1.85-3.76) and lower for cats with clinical illness
(OR = 0.60, 95% CI: 0.52-0.90). The variance components obtained from the model indicated clustering at the testing
facility level.
Conclusions: Risk factors that have a greater effect on FIV seropositivity include adulthood, being male (neutered or
not) and having access to outdoors, while clinical illness was a stronger predictor for FeLV seropositivity. Further studies
are warranted to assess the implications of these results for the management and control of these infections.
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Infections with feline immunodeficiency virus (FIV)
and feline leukemia virus (FeLV) are two of the most
common and important infectious diseases of cats
[1,2]. The most common mode of transmission of FIV
is through bites [3,4]. FeLV infection is also commonly
acquired via the oro-nasal route through mutual
grooming, nursing or sharing of dishes apart from bites
[3]. The known risk factors for acquiring these infec-
tions are male sex, adulthood and exposure to out-
doors, whereas being neutered and indoor lifestyle are* Correspondence: bchhetri@uoguelph.ca
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unless otherwise stated.known protective factors [5]. However, the relative im-
portance attributed to age, outdoor exposure and sex
among infected cats is variable in the literature. Some
studies indicate that FeLV infections are age-dependent
[6] and primarily acquired by “friendly” cats through pro-
longed close contact between virus shedders and suscep-
tible cats through mutual grooming, sharing of food and
water dishes, and use of common litter areas [3]. However,
other studies have indicated adulthood [1,7], outdoor life-
style [1,7], being not neutered [8], and fighting [8,9], fac-
tors commonly associated with FIV, to also be associated
with FeLV infection. Thus, further research is necessary to
investigate the relative importance of these factors to help
in management and prevention of these infections.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,





n (%, 95% CI) n (%, 95% CI)
Testing Site
Veterinary Clinic 1064 503 (47.3, 44.2-50.3) 561 (52.7, 49.7-55.8)
Shelter 225 90 (40.0, 33.5-46.7) 135 (60.0, 53.3-66.5)
Age
Juvenile 281 165 (58.7, 52.7-64.5) 116 (41.3, 35.5-47.3)
Adult 1008 428 (42.5, 39.4-45.6) 580 (57.5, 54.4 -60.6)
Sex
Male Intact 469 174 (37.1, 32.7-41.6) 295 (62.9, 58.4-67.3)
Male Neutered 380 147 (38.7, 33.8-43.8) 233 (61.3, 56.2-66.2)
Female Intact 262 167 (63.7, 57.6-69.6) 95 (36.3, 30.4-42.4)
Female Spayed 178 105 (59.0, 51.4-66.3) 73 (41.0, 33.7-48.6)
Outdoor Exposure
No 217 126 (58.1, 51.2-64.7) 91 (41.9, 35.3-48.8)
Yes 1072 467 (43.6, 40.6-46.6) 605 (56.4, 53.4-59.4)
Health Status
Healthy 708 303 (42.8, 39.1-46.5) 405 (57.2, 53.5-60.9)
Ill 581 290 (49.9, 45.8-54.1) 291 (50.1, 45.9-54.2)
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demiology to examine the strength, magnitude and dir-
ection of associations between exposure variables and an
outcome of interest [10]. Case-case studies are a variant
of case–control studies when the disease of interest can
be sub-classified in two or several groups that may have
distinct risk factors [11]. A case–case study differs from
a case–control study in that the comparison group (or
controls) are also selected among the cases, typically
with same disease but a different strain or serotype, from
the same surveillance system [11]. The case-case study
approach has been used increasingly in epidemiology
e.g. to compare risk factors for two subtypes of the
same disease with the goal of ascertaining relative im-
portance of risk factors for either subtype [11]. The
main advantage of the case-case design is its ability to
limit selection and information biases: control cases
have similar clinical features, are identified through the
same system and are subject to the same biases as
cases [11,12]. The goal of this study was to assess the
relative importance of known risk factors between the
two common feline retroviral infections, FIV and FeLV,
using the case-case study approach.
Methods
Data source and study participants
A dataset consisting of diagnostic test results from 29,182
cats tested for FIV and FeLV between August and November
of the year 2004 and 2007 from the United States (US) and
Canada was obtained from two previous cross-sectional
studies [1,7]. The cats included in these studies were con-
veniently sampled from veterinary clinics and animal shelters
across 40 contiguous states of the US and 9 Canadian prov-
inces encompassing 641 US zip codes and Canadian forward
sortation areas in 346 US counties and Canadian Census
Divisions. The first study investigated cats in the US
and Canada while the second study was restricted to
the Canadian cat population.
Data collection has been described elsewhere [1,7].
Briefly, potential veterinary clinic participants in the US
were identified from the membership roster of the
American Association of Feline Practitioners (AAFP) as
well as from the list of all individuals who had purchased
test kits for FIV and FeLV. Potential animal shelter par-
ticipants (including cat rescue organisations, and groups
participating in Trap-Neuter-Release (TNR) programs)
were derived from various Internet directories [1]. In
Canada, potential veterinary clinic and animal shelter
(including cat rescue programs and feral cat programs in
Canada) participants were identified as all those who
had purchased test kits for FIV or FeLV or submitted
samples to a diagnostic laboratory [7]. Potential study
participants were sent an invitation letter to participate
in the study. Enrolled participants submitted the diagnosticresults for FIV and FeLV along with information on age,
sex, neuter status, outdoor exposure, health status and test
date using a standard reporting form. The testing and
reporting was performed from August to November 2004
for the American and Canadian participants in the first
study and from August to November 2007 for the Canadian
participants in the second study.Testing protocol
The testing for FIV and FeLV was carried out in-house or
in-laboratory employing a commercially available ELISA
(SNAP® Combo FeLV antigen/FIV antibody, PetCheck®
FIV Antibody and PetCheck® FeLV Antigen; IDEXX
Laboratories) using whole blood, serum or plasma. The
manufacturer reported sensitivity and specificity of the
assay for detecting FeLV antigen of 97.6% and 99.1%, and
for detecting FIV antibodies of 100% and 99.5%, respect-
ively. Confirmatory testing was not performed.Covariate information
Information on postal code of testing facility, type of
testing facility (clinic or shelter), age of the cat (juvenile
[<6 months] or adult), sex and neuter status (sexually in-
tact female, spayed female, sexually intact male or neu-
tered male), access to outdoors (indoors or outdoors)
and general health at time of testing (healthy or sick)
was also retrieved from the dataset (Table 1).
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Cats testing positive for FIV antibodies in ELISA were
compared to cats testing positive for FeLV antigen with
all the cats having been tested for both infections. Cats
were excluded from further analysis in this study if they
tested positive for both FIV and FeLV.
Logistic regression
Logistic regression models were fit to model the logit of
the probability of FIV seropositivity as a function of pre-
dictor variables age, sex/neuter status, outdoor exposure,
health status and testing facility in a random intercept
logistic regression model framework.
Univariable analysis
Variables were screened for inclusion into the multivari-
able logistic regression model by fitting univariable logis-
tic regression models, without random intercepts, and
those predictor variables with a liberal significance level
(α = 0.2) were selected. However, care was taken not to
remove predictor variables that were deemed clinically
relevant. Since all the predictor variables were categor-
ical (i.e. indicator variables), the significance in the
model of each group of the predictors was analyzed by
applying a likelihood ratio test. Collinearity among the
predictor variables with significant unconditional associ-
ation with FIV seropositivity was assessed by using the
Spearman rank-correlation test. When two variables were
collinear, the one with the smaller P-value was considered
for further multivariable analysis while the other was
removed.
Multivariable analysis
Backward selection was employed for multivariable model
building and covariate removal from the model was based
on the following criteria: (1) the highest non-significant
P-value (with significance level α = 0.05); (2) a likeli-
hood ratio test of the model with and without the vari-
able that was non-significant and (3) the variable was
not an important confounder for other variables in the
model. A confounder was a non-intervening covariate
whose removal from the model resulted in greater than
20% change in coefficients on the log-odds scale for
any of the remaining variables in the model. Two-way
interaction terms among type of testing facility, health
status, outdoor exposure, age and sex were also assessed
for statistical significance. However, interaction terms
were dropped when these led to sparse cells and un-
realistic estimates. Multicollinearity was tested among
screened variables in the multivariable logistic regression
model by estimating the variance inflation factor (VIF).
All variables with a VIF value of 10 or above were consid-
ered to indicate multicollinearity, assuming that this was
not due to variable construction (e.g. interaction terms)[10]. Non-nested multivariable models were compared
using the Akaike Information Criterion (AIC), and the
model with lowest AIC value was considered to be better
fitting.
To account for clustering by testing facility (i.e. clinics
or shelters), all multivariable logistic regression models
included a random intercept for testing facility. Rele-
vance of the random effect term for facility ID was
assessed by inspection of the variance component. A
simpler model (without random effects) was chosen
when the variance component was close to zero [13].
Fit of the random effect model was assessed visually
by plotting the QQ-plots of the Best Linear Unbiased
Predictors (BLUPs) against the normal scores [10].
The random intercept models were fit in statistical
software R (lme4 package) and Stata (xtmelogit) by
seven point Gauss-Hermite adaptive quadrature method
[14,15], using complete cases (i.e., any observations with
missing values excluded from the analysis). However, the
point estimates from the final model were compared to
the same model fit with missing values (coded as un-
known) to observe any gross deviation in direction and
magnitude.
The Research Ethics Board at the University of Guelph
did not require ethics approval for this study because




Table 1 presents the descriptive statistics of FIV and
FeLV cases cross-tabulated by risk factors. The total
number of cases included in this study was 1289. Out of
these retroviral cases, 696 tested positive for FIV and
593 for FeLV.
Logistic regression analysis
All covariates met the inclusion criteria for multivariable
modeling as explained above (Table 2). The final multi-
variable random intercept logistic regression model in-
cluded the covariates/predictors age, sex/neuter status,
outdoor exposure, and health status of cats (Table 3).
The odds ratio (OR) associated with each variable is ad-
justed for the remaining variables in the model. No sig-
nificant interactions were detected between the variables
that remained in the final multivariable model.
The odds of cats being seropositive for FIV relative to
FeLV was significantly greater for adult cats than juven-
ile cats (Table 3). Similarly, the intact and neutered
males were significantly more likely to be seropositive
for FIV than FeLV compared to intact females. The odds
of being seropositive for FIV relative to FeLV was not
significantly different between intact and spayed females
based on the Wald test. Compared to cats kept indoors,
Table 2 Results of univariable logistic regression analysis
of risk factors for infection to FIV compared to FeLV
Variable β OR (95% CI)a P (Wald test) P (LR test)b
Type 0.046
Clinic Ref.
Shelter 0.296 1.34 (1.00,1.80) 0.047
Age <0.001
Juvenile Ref.





Spayed Female 0.201 1.22 (0.83,1.81) 0.314
Intact Male 1.092 2.98 (2.18,4.08) <0.001
Neutered male 1.025 2.79 (2.01,3.86) <0.001
Outdoor Exposure <0.001
Indoor Ref.
Outdoor 0.584 1.79 (1.33,2.41) <0.001
Health Status 0.006
Healthy Ref.
Ill −0.287 0.75 (0.60,0.94) 0.011
a: Odds Ratios and 95% Confidence Intervals.
b: Likelihood Ratio Test p-value.
Table 3 Results of the final mixed effects multivariable
logistic regression model for analysis of risk factors for
infection with FIV compared to FeLV
Variable OR (95% CI)a P (Wald test)
Age
Juvenile Ref.
Adult 2.09 (1.50-2.92) <0.001
Sex and neuter status
Intact Female Ref.
Spayed Female 1.35 (0.66-1.65) 0.227
Intact Male 3.14 (1.85-3.76) <0.001
Neutered Male 2.68 (1.44-3.14) <0.001
Outdoor Exposure
Indoor Ref.
Outdoor 2.58 (1.74-3.93) <0.001
Health Status
Healthy Ref.
Ill 0.60 (0.52-0.90) <0.001
Random effects Variance SE 95% CI
At testing facility level 1.196 0.25 1.06-1.77
a: Odds Ratios and 95% Confidence Intervals.
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ing seropositive for FIV relative to FeLV. For clinically ill
cats, the odds of being seropositive for FIV relative to FeLV
were smaller compared to cats without clinical illness.
The variance components obtained from the multi-
level logistic regression model for the individual level
and clinic/shelter level were 3.29 and 1.16, respectively.
A random effects logistic regression model was deemed
appropriate due to clustering expected for cats tested
within the same facility and because the variance of the
random effect was 3.29, which given the associated small
standard error was interpreted as the variance being dif-
ferent from zero (Table 3). Normal quantile plot of the
BLUPs indicated no gross deviation from normality.
Discussion
This case-case study is based on cross-sectional or
prevalence data and thus generally not suited to identify
risk factors. However, only known risk factors [3] were
evaluated in this study with respect to their importance
as risk factors for infection with FIV compared to FeLV.
The results from this study imply that risk factors com-
monly associated with FIV and FeLV differ in their rela-
tive effects for these two diseases. For example adult,
male, or outdoor cats are more likely to be seropositive
for FIV than FeLV when compared to juvenile, female
or cats kept exclusively indoors. In contrast, neuter
status was not significantly different for either infec-
tion. Further, whether cats were tested at clinics or
shelters was not different for these infections.
Most FIV infections are acquired as a consequence of
bite wounds inflicted by an infected cat, presumably
through inoculation of virus or virus infected cells
[16,17]. Although, vertical transmission of infection from
queen to kitten may occur, it is considered rare [18].
Adult, male, outdoor exposed cats would be expected to
have a higher likelihood of getting infected with FIV due
to higher likelihood of encountering infected cats, and
being prone to aggression and territorial fights. On the
contrary, most FeLV infections occur after oro-nasal
spread of the virus from the viremic cats [17,19-22].
FeLV infection, thus, is a concern in cats that are
“friendly” and in close contact with infected cats through
nursing, mutual grooming or sharing dishes, but also
through bites [3].
This study found a higher likelihood of FIV (compared
to FeLV) seropositivity in adults. In contrast to FIV,
FeLV is reported to be age dependent with older cats be-
coming increasingly resistant to infection [23,24]. Of
note, however, is the fact that while age at acquisition is
similar for both infections, FeLV can cause serious, often
fatal, disease. As a result, FeLV-infected cats have shorter
survival rates [25,26] and not many live to adulthood,
while most FIV infected cats do.
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males compared to females for FIV [9,27-37]. But for
FeLV, most studies did not find an association between
sex and seropositivity [28,38] except for a single report
[9]. The association between male sex and FIV infection
has been primarily related to increased risk of infection
transmission due to greater predisposition of males to
exhibit territorial behaviour involving fighting. In this
study, regression models included contrasts to compare
the likelihood of seropositivity of FIV between intact and
neutered male cats as well as between intact and spayed
female cats. Although, compared to females, males were
found to be more likely to test seropositive for FIV
compared to FeLV, no significant differences were evi-
dent between intact and neutered cats for the same sex
(Table 3 and 4). Various studies have reported an asso-
ciation between neutering and lower risk of infection
of FIV and FeLV among domestic cats [8]. However,
there are reports suggesting that neutering and spaying
have no significant effect on the prevalence of FIV
[27,39,40] and that such cats still retain territorial ag-
gressiveness [39,40]. It should be noted that when a
predictor is common to both FIV and FeLV, due to its
inherent design, a case–case study might not detect a
difference between the two case groups. In other
words, if neutering were significantly associated with
both FIV and FeLV seropositivity, this study design
would not detect it. Since a higher likelihood of sero-
positivity was found in intact compared to neutered
cats when non-infected cats were included [1,7], it is
possible that sterilization characteristics are not differ-
ent between FIV and FeLV infected cats.
Cats were more likely seropositive for FIV than FeLV
when exposed to outdoors than being indoors. This find-
ing suggests that outdoor exposure is more important to
acquire FIV infection than FeLV. Considering prevalence
studies where non-infected cats were included, there
seems to be consensus that the probability of FIV infection
is higher for cats that roam outdoors [9,41] due increased
opportunity for transmission via fights. In contrast, the re-
lationship between outdoor exposure and FeLV infection is
not very clear.Table 4 Contrasts for the association between FIV
seropositivity and sex/neuter characteristics compared to
FeLV seropositivity
Contrast OR (95% CI)a P (Wald test)
Spayed female vs. Intact male
(Referent category)
0.43 <0.001
Neutered male vs. Intact male
(Referent category)
0.85 0.374
Neutered male vs. Spayed female
(Referent category)
1.98 <0.005
a Odds ratio for the contrast after adjusting for age, outdoor exposure and
health status.Healthy cats were more likely to test positive for FIV
than FeLV compared to cats presenting as ill at the time
of testing. Both viruses induce immunodeficiency, but
FeLV is more rapidly pathogenic and its effects manifest
sooner and include other disease conditions [26]. FIV in-
fection causes gradually developing immunodeficiency
and has only a minor impact on lifespan. Therefore, cats
with FeLV are more likely to be presented with illness.
This contributes to more sick cats testing FeLV positive
rather than FIV positive.
The variance components of the random effects model
indicate that some degree of clustering was evident at
testing facility (ICC = 0.26) suggesting that FIV seroposi-
tive status compared to FeLV was not independent of
shelter or clinic.
A few important limitations of the case-case study de-
sign in the context of this study merits attention. For a
detailed account of pros and cons of case-case studies in
general the reader is referred to McCarthy and Giesecke
[11]. This study entailed comparison of FIV seropositive
cats to FeLV seropositive cats with regard to known risk
factors and explored the strength of their effects between
the two infections. Therefore, care should be taken before
extrapolating results of this study to the general population
with non-infected cats. The risk factors that are common
to both comparison groups tend to be underestimated or
unidentified in a case-case study [11,12]. Since the study
does not include a disease-free population, the odds ratios
can only be interpreted as the odds of exposure to one dis-
ease group (FIV) in reference to the other (FeLV), and do
not provide the estimate of the association between a risk
factor and disease in the general population [42,43].Conclusion
In conclusion, while similar risk factors have been re-
ported for both FIV and FeLV infection, this study dem-
onstrated, through comparison of one infection with the
other, that adulthood, being male (neutered or not) and
having access to outdoors are of greater importance to
FIV seropositivity compared to FeLV. Clinical illness was
a stronger predictor for FeLV seropositivity. Further stud-
ies are warranted to assess the implications of these find-
ings in regard to the management and control of these
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